Health Care & Life Sciences » Pharmaceuticals | Abbott Laboratories

Abbott Laboratories | Ownership

Companies that own Abbott Laboratories

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
134,233,451
7.65%
2,887,343
0.28%
06/30/2018
Capital Research & Management Co. (Global Investors)
131,099,788
7.47%
18,000,566
1.59%
06/30/2018
BlackRock Fund Advisors
77,540,994
4.42%
-1,578,501
0.26%
06/30/2018
SSgA Funds Management, Inc.
67,180,598
3.83%
-1,449,779
0.34%
06/30/2018
Wellington Management Co. LLP
41,733,161
2.38%
-2,064,549
0.52%
06/30/2018
Massachusetts Financial Services Co.
39,138,499
2.23%
-674,986
0.84%
06/30/2018
Northern Trust Investments, Inc.
26,206,394
1.49%
146,145
0.39%
06/30/2018
Geode Capital Management LLC
19,996,903
1.13%
789,837
0.34%
06/30/2018
T. Rowe Price Associates, Inc.
18,816,823
1.07%
-782,136
0.17%
06/30/2018
Norges Bank Investment Management
18,689,945
1.07%
1,317,283
0.18%
12/31/2017

About Abbott Laboratories

View Profile
Address
100 Abbott Park Road
Abbott Park Illinois 60064
United States
Employees -
Website http://www.abbott.com
Updated 07/08/2019
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products.